Sitemap
May 19, 2023 Articles
Filter by Available Specialty
- ‘Unfavorable benefit-risk’: FDA panel votes against obeticholic acid approval for NASH
- 5-year data show titanium-nitride-oxide coated stents may be safer than DES
- About 45% of teens with obesity improve to overweight or normal weight with semaglutide
- Accelerated, conservative rehabilitation after hip arthroscopy may yield similar outcomes
- ACG, AGA guideline first to recommend magnesium oxide, senna for chronic constipation
- ACOG meeting holds strong focus on legality of abortion, provider mental health
- APA hosts annual meeting in San Francisco
- BLOG: Post-concussion coping mechanism may predict long-term symptoms
- Combination chemoprevention topical treatment reduces keratinocyte carcinoma incidence
- Deep brain stimulation effective, cost-efficient option for advanced Parkinson’s
- ESC guideline may help risk stratify patients with non ST-elevation ACS undergoing PCI
- FDA approves Epkinly for treatment of advanced diffuse large B-cell lymphoma
- FDA approves sensor-enabled atrial fibrillation ablation catheter
- FDA approves Vyjuvek for dystrophic epidermolysis bullosa
- FDA clears next-generation insulin pump with algorithm-based insulin dosing software
- Febrile toddler presents with painful neck mass
- Fezolinetant reduces hot flashes associated with menopause in diverse population
- Gene therapy a potential ‘functional cure’ for sickle cell disease, beta thalassemia
- Hooked on Rheum with Randy Q. Cron, MD, PhD
- In proclamation, Biden notes ‘hidden epidemic’ of viral hepatitis
- Information sheet after lung cancer screening results helpful, but discussion still needed
- LEAF: Weight loss before procedure confers better atrial fibrillation ablation outcomes
- Mavorixafor reduces infection rates among patients with WHIM syndrome
- Novel leukemia treatment signals ‘new era in CAR T-cell therapy’
- Odds of preterm birth in American Indian/Alaska Native population rose during pandemic
- Oral Bruton’s tyrosine kinase inhibitor reduced brain lesions in phase 2 MS trial
- Perceived cognitive deficits in first 4 weeks of COVID-19 could predict long COVID
- Q&A: AI ready to assist, not replace, human beings in asthma, allergy care
- Q&A: Rapid-acting medications needed to treat ‘devastating’ postpartum depression
- Ray Therapeutics closes $100 million in oversubscribed Series A financing
- Screening for common genetic conditions may be cost-effective
- Stroke rate higher in East Asian vs. white adults, regardless of relationship to AF
- Ticagrelor monotherapy after PCI poses no extra revascularization risk vs. continued DAPT
- Top in allergy/asthma: Epinephrine nasal spray; immunotherapies for multiple foods
- Top news in pregnancy: updates on mifepristone, preterm birth prevention and more
- Transcatheter edge-to-edge repair system improved severe tricuspid regurgitation
- US Renal Care raises $328 million for innovation, value-based care
- VIDEO: enVista toric IOL features improved rotational stability
- VIDEO: Promising results reported for cell therapy in corneal endothelial disease
- VIDEO: Speaker advises MPFL reconstruction for first-time patellar instability